Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients.
Mantelli M, Pastorino L, Ghiorzo P, Barile M, Bruno W, Gargiulo S, Sormani MP, Gliori S, Vecchio S, Ciotti P, Sertoli MR, Queirolo P, Goldstein AM, Bianchi-Scarrà G; Italian Melanoma Intergroup.
Mantelli M, et al. Among authors: sormani mp.
Melanoma Res. 2004 Dec;14(6):443-8. doi: 10.1097/00008390-200412000-00002.
Melanoma Res. 2004.
PMID: 15577313